{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T03:31:21Z","timestamp":1784345481558,"version":"3.55.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100013066","name":"Key Scientific Research Project of Colleges and Universities in Henan Province","doi-asserted-by":"publisher","award":["25A350008"],"award-info":[{"award-number":["25A350008"]}],"id":[{"id":"10.13039\/501100013066","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U21A20416"],"award-info":[{"award-number":["U21A20416"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017700","name":"Henan Provincial Science and Technology Research Project","doi-asserted-by":"publisher","award":["252102311234"],"award-info":[{"award-number":["252102311234"]}],"id":[{"id":"10.13039\/501100017700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.ejpb.2026.115093","type":"journal-article","created":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T15:31:26Z","timestamp":1778167886000},"page":"115093","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Cholesterol-butyl-biguanide conjugate as a novel excipient enhances the efficacy of doxorubicin liposomes against triple-negative breast cancer by potentiating immunogenic cell death"],"prefix":"10.1016","volume":"225","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4570-1711","authenticated-orcid":false,"given":"Yanzhi","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanting","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxin","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongmin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ejpb.2026.115093_b0005","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.ejpb.2026.115093_b0010","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13058-020-01296-5","article-title":"Triple-negative breast cancer molecular subtyping and treatment progress","volume":"22","author":"Yin","year":"2020","journal-title":"Breast Cancer Res."},{"issue":"20","key":"10.1016\/j.ejpb.2026.115093_b0015","doi-asserted-by":"crossref","first-page":"6021","DOI":"10.3390\/jcm11206021","article-title":"Current therapeutic strategies for metastatic triple-negative breast cancer: from pharmacists' perspective","volume":"11","author":"Li","year":"2022","journal-title":"J. Clin. Med."},{"issue":"1","key":"10.1016\/j.ejpb.2026.115093_b0020","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/s41523-022-00468-0","article-title":"Triple negative breast cancer: pitfalls and progress","volume":"8","author":"Zagami","year":"2022","journal-title":"npj Breast Cancer"},{"key":"10.1016\/j.ejpb.2026.115093_b0025","article-title":"Optimal strategies for the treatment of metastatic triple-negative breast cancer with currently approved agents","volume":"23 Suppl 6","author":"Andr\u00e9","year":"2012","journal-title":"Ann. Oncol."},{"issue":"4","key":"10.1016\/j.ejpb.2026.115093_b0030","doi-asserted-by":"crossref","first-page":"6349","DOI":"10.1021\/acsnano.2c00423","article-title":"PEGylated Liposomes Accumulate in the areas Relevant to Skin Toxicities via Passive Extravasation across \u201cLeaky\u201d Endothelium","volume":"16","author":"Li","year":"2022","journal-title":"ACS Nano"},{"issue":"2","key":"10.1016\/j.ejpb.2026.115093_b0035","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jconrel.2012.03.020","article-title":"Doxil\u00ae\u2013the first FDA-approved nano-drug: lessons learned","volume":"160","author":"Barenholz","year":"2012","journal-title":"J. Control. Release"},{"issue":"3","key":"10.1016\/j.ejpb.2026.115093_b0040","doi-asserted-by":"crossref","first-page":"893","DOI":"10.3390\/pharmaceutics15030893","article-title":"Recent Preclinical and Clinical Progress in Liposomal Doxorubicin","volume":"15","author":"Aloss","year":"2023","journal-title":"Pharmaceutics"},{"issue":"7","key":"10.1016\/j.ejpb.2026.115093_b0045","doi-asserted-by":"crossref","first-page":"6758","DOI":"10.1021\/acsnano.4c10202","article-title":"A pH-responsive and guanidinium-rich nanoadjuvant efficiently delivers STING agonist for cancer immunotherapy","volume":"19","author":"Lu","year":"2025","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.ejpb.2026.115093_b0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/1389450023348082","article-title":"Progress in gene delivery by cationic lipids: guanidinium-cholesterol-based systems as an example","volume":"3","author":"Aissaoui","year":"2002","journal-title":"Curr. Drug Targets"},{"issue":"18","key":"10.1016\/j.ejpb.2026.115093_b0055","doi-asserted-by":"crossref","first-page":"17799","DOI":"10.1021\/acsnano.3c03269","article-title":"Guanidyl-rich poly(\u03b2 amino ester)s for universal functional cytosolic protein delivery and clustered regularly interspaced short palindromic repeats (CRISPR) Cas9 ribonucleoprotein based gene editing","volume":"17","author":"Wang","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.ejpb.2026.115093_b0060","unstructured":"F. Madani SL, \u00dc S.F. Langel, A. Gr\u00e4slund. Mechanisms of cellular uptake of cell\u2010penetrating peptides. J. Biophys. 2011. 2011: 414729."},{"key":"10.1016\/j.ejpb.2026.115093_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.progpolymsci.2023.101751","article-title":"Functionalization of polymers for intracellular protein delivery","volume":"146","author":"Zhang","year":"2023","journal-title":"Prog. Polym. Sci."},{"issue":"6","key":"10.1016\/j.ejpb.2026.115093_b0070","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3390\/membranes15060173","article-title":"Comprehensive insights into the cholesterol-mediated modulation of membrane function through molecular dynamics simulations","volume":"15","author":"Khodadadi","year":"2025","journal-title":"Membranes (Basel)"},{"key":"10.1016\/j.ejpb.2026.115093_b0075","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ejpb.2016.03.023","article-title":"Insertion stability of poly(ethylene glycol)-cholesteryl-based lipid anchors in liposome membranes","volume":"103","author":"Molnar","year":"2016","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2026.115093_b0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.121509","article-title":"Magnolol-loaded cholesteryl biguanide conjugate hydrochloride nanoparticles for triple-negative breast cancer therapy","volume":"615","author":"Wang","year":"2022","journal-title":"Int. J. Pharm."},{"issue":"3","key":"10.1016\/j.ejpb.2026.115093_b0085","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1007\/s13346-023-01433-5","article-title":"Enhancing anti-tumor therapy with agmatine-cholesterol conjugate liposomes: in vitro and in vivo evidence","volume":"14","author":"Wang","year":"2024","journal-title":"Drug Deliv. Transl. Res."},{"issue":"1\u20132","key":"10.1016\/j.ejpb.2026.115093_b0090","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.ijpharm.2018.09.047","article-title":"A study on the role of cholesterol and phosphatidylcholine in various features of liposomal doxorubicin: from liposomal preparation to therapy","volume":"551","author":"Farzaneh","year":"2018","journal-title":"Int. J. Pharm."},{"issue":"1\u20132","key":"10.1016\/j.ejpb.2026.115093_b0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2017.01.002","article-title":"Distinct biodistribution of doxorubicin and the altered dispositions mediated by different liposomal formulations","volume":"519","author":"Luo","year":"2017","journal-title":"Int. J. Pharm."},{"issue":"4","key":"10.1016\/j.ejpb.2026.115093_b0100","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.breast.2009.05.004","article-title":"Improving the therapeutic index of anthracycline chemotherapy: focus on liposomal doxorubicin (Myocet)","volume":"18","author":"Leonard","year":"2009","journal-title":"Breast"},{"key":"10.1016\/j.ejpb.2026.115093_b0105","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.biomaterials.2014.10.073","article-title":"Mulberry-like dual-drug complicated nanocarriers assembled with apogossypolone amphiphilic starch micelles and doxorubicin hyaluronic acid nanoparticles for tumor combination and targeted therapy","volume":"39","author":"Li","year":"2015","journal-title":"Biomaterials"},{"issue":"3","key":"10.1016\/j.ejpb.2026.115093_b0110","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1021\/acsomega.7b01235","article-title":"Cardinal Role of Intraliposome Doxorubicin-Sulfate Nanorod Crystal in Doxil Properties and Performance","volume":"3","author":"Wei","year":"2018","journal-title":"ACS Omega"},{"issue":"2","key":"10.1016\/j.ejpb.2026.115093_b0115","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0005-2736(93)90105-9","article-title":"Transmembrane ammonium sulfate gradients in liposomes produce efficient and stable entrapment of amphipathic weak bases","volume":"1151","author":"Haran","year":"1993","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejpb.2026.115093_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2025.118396","article-title":"Discovery of hydroxamate derivatives as potent anti-gastric cancer agents via inducing oxidative stress and DNA damage","volume":"131","author":"Xu","year":"2025","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejpb.2026.115093_b0125","doi-asserted-by":"crossref","unstructured":"X. Zhang, H. Kang, B. Li, et al. Structural optimization of 1,3-diaryl-1,2,4-triazole-capped histone deacetylase 6 inhibitors to obtain novel antiesophageal cancer candidates. J. Med. Chem. 2025. 12;68(11):10991-11016.","DOI":"10.1021\/acs.jmedchem.4c03231"},{"issue":"1","key":"10.1016\/j.ejpb.2026.115093_b0130","doi-asserted-by":"crossref","first-page":"6502","DOI":"10.1038\/s41598-025-91248-w","article-title":"Primary astrocytes as a cellular depot of polystyrene nanoparticles","volume":"15","author":"Adamiak","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejpb.2026.115093_b0135","doi-asserted-by":"crossref","first-page":"43036","DOI":"10.1038\/srep43036","article-title":"Cationic polymethacrylate-modified liposomes significantly enhanced doxorubicin delivery and antitumor activity","volume":"7","author":"Wang","year":"2017","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.ejpb.2026.115093_b0140","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41392-024-01955-5","article-title":"Multi-stage mechanisms of tumor metastasis and therapeutic strategies","volume":"9","author":"Liu","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"issue":"11","key":"10.1016\/j.ejpb.2026.115093_b0145","doi-asserted-by":"crossref","first-page":"559","DOI":"10.3390\/pharmaceutics11110559","article-title":"Metformin-encapsulated liposome delivery system: an effective treatment approach against breast cancer","volume":"11","author":"Shukla","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2026.115093_b0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120572","article-title":"Pulmonary delivery of cationic liposomal hydroxycamptothecin and 5-aminolevulinic acid for chemo-sonodynamic therapy of metastatic lung cancer","volume":"601","author":"Xiao","year":"2021","journal-title":"Int. J. Pharm."},{"issue":"12","key":"10.1016\/j.ejpb.2026.115093_b0155","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1002\/1878-0261.12851","article-title":"Targeting immunogenic cell death in cancer","volume":"14","author":"Ahmed","year":"2020","journal-title":"Mol. Oncol."},{"issue":"6","key":"10.1016\/j.ejpb.2026.115093_b0160","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/s41573-024-00920-9","article-title":"Targeting immunogenic cell stress and death for cancer therapy","volume":"23","author":"Galluzzi","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejpb.2026.115093_b0165","article-title":"Nucleic acid-based nanogels with \u201coffensive and defensive\u201deffects for enhanced chemo-immunotherapy","volume":"385","author":"Zhao","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2026.115093_b0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114503","article-title":"Immunogenic cell death inducer peptides: a new approach for cancer therapy, current status and future perspectives","volume":"161","author":"Aria","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"5381","key":"10.1016\/j.ejpb.2026.115093_b0175","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1126\/science.281.5381.1309","article-title":"Mitochondria and apoptosis","volume":"281","author":"DR Green JCR","year":"1998","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.ejpb.2026.115093_b0180","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/s12276-024-01192-4","article-title":"Extramedullary hematopoiesis in cancer","volume":"56","author":"Barisas","year":"2024","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.ejpb.2026.115093_b0185","doi-asserted-by":"crossref","unstructured":"D. Cenariu SI, A.A. Zimta BP, L. Qian ND, C. Tomuleasa HB. Extramedullary hematopoiesis of the liver and spleen. J. Clin. Med. 2021.10(24):5831.","DOI":"10.3390\/jcm10245831"}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641126001141?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641126001141?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T11:53:58Z","timestamp":1783079638000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641126001141"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":37,"alternative-id":["S0939641126001141"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2026.115093","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cholesterol-butyl-biguanide conjugate as a novel excipient enhances the efficacy of doxorubicin liposomes against triple-negative breast cancer by potentiating immunogenic cell death","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2026.115093","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115093"}}